The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study

被引:12
|
作者
Shafer, Leigh Anne [1 ,2 ]
Nsubuga, Rebecca N. [2 ]
Chapman, Ruth [3 ]
O'Brien, Katie [3 ]
Mayanja, Billy N. [2 ]
White, Richard G. [3 ]
机构
[1] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 3P5, Canada
[2] Uganda Virus Res Inst, Med Res Council Unit AIDS, Entebbe, Uganda
[3] London Sch Hyg & Trop Med, London WC1, England
基金
英国医学研究理事会;
关键词
RURAL-POPULATION; INFECTION; TRANSMISSION; PREVENTION; RISK; INTERVENTIONS; PREVALENCE;
D O I
10.1136/sextrans-2013-051219
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives Antiretroviral therapy (ART) availability in a population may influence risky sexual behaviour. We examine the potential impact of ART on the HIV epidemic, incorporating evidence for the impact that ART may have on risky sexual behaviour. Methods A mathematical model, parameterised using site-specific data from Uganda and worldwide literature review, was used to examine the likely impact of ART on HIV epidemiologic trends. We varied assumptions about rates of initiating ART, and changes in sexual partner turnover rates. Results Modelling suggests that ART will reduce HIV incidence over 20 years, and increase prevalence. Even in the optimistic scenario of ART enrollment beginning after just five months of infection (in HIV stage 2), prevalence is estimated to rise from a baseline of 10.5% and 8.3% among women and men, respectively, to at least 12.1% and 10.2%, respectively. It will rise further if sexual disinhibition occurs or infectiousness while on ART is slightly higher (2% female to male, rather than 0.5%). The conditions required for ART to reduce prevalence over this period are likely too extreme to be achievable. For example, if ART enrolment begins in HIV stage 1 (within the first 5 months of infection), and if risky sexual behaviour does not increase, then 3 of our 11 top fitting results estimate a potential drop in HIV prevalence by 2025. If sexual risk taking rises, it will have a large additional impact on expected HIV prevalence. Prevalence will rise despite incidence falling, because ART extends life expectancy. Conclusions HIV prevalence will rise. Even small increases in partner turnover rates will lead to an additional substantial increase in HIV prevalence. Policy makers are urged to continue HIV prevention activities, including promoting sex education, and to be prepared for a higher than previously suggested number of HIV infected people in need of treatment.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 50 条
  • [21] Two-Year Follow-Up of Sexual Behavior Among HIV-Uninfected Household Members of Adults Taking Antiretroviral Therapy in Uganda: No Evidence of Disinhibition
    Bechange, Stevens
    Bunnell, Rebecca
    Awor, Anna
    Moore, David
    King, Rachel
    Mermin, Jonathan
    Tappero, Jordan
    Khana, Kenneth
    Bartholow, Bradford
    AIDS AND BEHAVIOR, 2010, 14 (04) : 816 - 823
  • [22] The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study
    Wakeham, Katie
    Harding, Richard
    Levin, Jonathan
    Parkes-Ratanshi, Rosalind
    Kamali, Anatoli
    Lalloo, David G.
    BMC PALLIATIVE CARE, 2017, 17
  • [23] Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan
    Lai, Chung-Chih
    Hung, Chien-Ching
    Chen, Mao-Yuan
    Sun, Hsin-Yun
    Lu, Ching-Lan
    Tseng, Yu-Tzu
    Chang, Shu-Fang
    Su, Yi-Ching
    Liu, Wen-Chun
    Hsieh, Chia-Yin
    Wu, Pei-Ying
    Chang, Sui-Yuan
    Chang, Shan-Chwen
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (05) : 1254 - 1260
  • [24] Impact of Antiretroviral Therapy on Renal Function among HIV-Infected Tanzanian Adults: A Retrospective Cohort Study
    Mpondo, Bonaventura C. T.
    Kalluvya, Samuel E.
    Peck, Robert N.
    Kabangila, Rodrick
    Kidenya, Benson R.
    Ephraim, Lucheri
    Fitzgerald, Daniel W.
    Downs, Jennifer A.
    PLOS ONE, 2014, 9 (02):
  • [25] Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users
    Fu, Tsung-chieh
    Westergaard, Ryan P.
    Lau, Bryan
    Celentano, David D.
    Vlahov, David
    Mehta, Shruti H.
    Kirk, Gregory D.
    AIDS, 2012, 26 (18) : 2383 - 2391
  • [26] Cross-sectional comparative study of risky sexual behaviours among HIV-infected persons initiated and waiting to start antiretroviral therapy in rural Rakai, Uganda
    Nakiganda, Lydia Jacenta
    Nakigozi, Gertrude
    Kagaayi, Joseph
    Nalugoda, Fred
    Serwadda, David
    Sewankambo, Nelson
    Gray, Ronald
    Ndyanabo, Anthony
    Muwanika, Richard
    Asamoah, Benedict Oppong
    BMJ OPEN, 2017, 7 (09):
  • [27] Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study
    Piloya, Thereza
    Bakeera-Kitaka, Sabrina
    Kekitiinwa, Adeodata
    Kamya, Moses R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
  • [28] Alcohol Consumption and Tryptophan Metabolism Among People with HIV Prior to Antiretroviral Therapy Initiation: The Uganda ARCH Cohort Study
    Pierre, Frantz
    Forman, Leah S.
    Winter, Michael
    Cheng, Debbie
    Ngabirano, Christine
    Emenyonu, Nneka
    Hunt, Peter W.
    Huang, Yong
    Muyindike, Winnie
    Samet, Jeffrey
    Hahn, Judith A.
    So-Armah, Kaku
    ALCOHOL AND ALCOHOLISM, 2022, 57 (02): : 219 - 225
  • [29] Monitoring of Antiretroviral Therapy and Mortality in HIV Programmes in Malawi, South Africa and Zambia: Mathematical Modelling Study
    Estill, Janne
    Egger, Matthias
    Johnson, Leigh F.
    Gsponer, Thomas
    Wandeler, Gilles
    Davies, Mary-Ann
    Boulle, Andrew
    Wood, Robin
    Garone, Daniela
    Stringer, Jeffrey S. A.
    Hallett, Timothy B.
    Keiser, Olivia
    PLOS ONE, 2013, 8 (02):
  • [30] Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study
    Namale, Gertrude
    Kamacooko, Onesmus
    Bagiire, Daniel
    Mayanja, Yunia
    Abaasa, Andrew
    Kilembe, William
    Price, Matt
    Ssemwanga, Deogratius
    Lunkuse, Sandra
    Nanyonjo, Maria
    Ssenyonga, William
    Mayaud, Philippe
    Newton, Rob
    Kaleebu, Pontiano
    Seeley, Janet
    SEXUALLY TRANSMITTED INFECTIONS, 2019, 95 (06) : 405 - 411